TikoMed is interviewed at BioSpring about IBsolvMIR for improved cell-therapies by Mike Ward

Written on 2018-04-27

TikoMeds promising Phase 2 project for more efficient cell-therapies was presented at BioEurope Spring in Amsterdam. Below follows an interview by Mike Ward of Adam Bruce, Founder and CEO of TikoMed.

https://www.youtube.com/watch?v=VBPfEgJe-CM&feature=youtu.be